Primary |
---|
Acute/subacute dysautonomias |
Pure pandysautonomia |
Pandysautonomia with neurological features |
Chronic autonomic failure syndromes |
Pure autonomic failure |
Multiple system atrophy (Shy-Drager syndrome) |
Parkinson’s disease with autonomic failure |
Secondary |
Congenital |
Nerve growth factor deficiency |
Hereditary |
Autosomal dominant trait |
Familial amyloid neuropathy |
Autosomal recessive trait |
Familial dysautonomia: Riley-Day syndrome |
Dopamineβhydroxylase deficiency |
Metabolic |
Diabetes mellitus |
Chronic renal failure |
Inflammatory |
Guillain-Barré syndrome |
Transverse myelitis |
Infections |
Bacterial: tetanus |
Viral: human immunodeficiency virus infection |
Neoplasia |
Brain tumours: especially of posterior fossa |
Paraneoplastic, to include adenocarcinomas of lung and pancreas |
Surgery |
Splanchnic sympathectomy |
Trauma |
Spinal cord transection |
Drugs |
Direct effect |
Sympatholytic drugs: guanethidine |
Neuropathy |
Alcohol, vincristine, cisplatin |
Neurally mediated syncope* |
Vasovagal syncope |
Carotid sinus hypersensitivity |
Micturition syncope |
Cough syncope |
Swallow syncope |
Associated with glossopharyngeal neuralgia |
Adapted from Mathias4. *For mechanisms see text.